- PMID: 33409086
- PMCID: PMC7781576
- DOI: 10.7759/cureus.11848
Abstract
Objective: The opioid epidemic continues to claim thousands of lives every year without an effective strategy useful in mitigating mortality. The use of medical cannabis has been proposed as a potential strategy to decrease opioid usage. The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronic pain patients.
Methods: We conducted an online convenience sample survey of patients from three medical cannabis practice sites who had reported using opioids. A total of 1181 patients responded, 656 were excluded for not using medical cannabis in combination with opioid use or not meeting the definition of chronic pain, leaving 525 patients who had used prescription opioid medications continuously for at least three months to treat chronic pain and were using medical cannabis in combination with their prescribed opioid use.
Results: Overall, 40.4% (n=204) reported that they stopped all opioids, 45.2% (n=228) reported some decrease in their opioid usage, 13.3% (n=67) reported no change in opioid usage, and 1.1% (n=6) reported an increase in opioid usage. The majority (65.3%, n=299) reported that they sustained the opioid change for over a year. Almost half (48.2%, n=241) reported a 40-100% decrease in pain while 8.6% (n=43) had no change in pain and 2.6% (n=13) had worsening pain. The majority reported improved ability to function (80.0%, n=420) and improved quality of life (87.0%, n=457) with medical cannabis. The majority (62.8%, n=323) did not want to take opioids in the future. While the change in pain level was not affected by age and gender, the younger age group had improved ability to function compared with the middle and older age groups.
Conclusions: Patients in this study reported that cannabis was a useful adjunct and substitute for prescription opioids in treating their chronic pain and had the added benefit of improving the ability to function and quality of life.
Keywords: chronic pain, marijuana, medical cannabis, opioid use, survey
Copyright © 2020, Takakuwa et al.
Conflict of interest statement
Kevin Takakuwa is the chair of the research committee for the Society of Cannabis Clinicians. Dustin Sulak is a board member of the Society of Cannabis Clinicians. Both are unpaid positions
Similar articles
-
The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage.Cannabis Cannabinoid Res. 2020 Sep 2;5(3):263-270. doi: 10.1089/can.2019.0039. eCollection 2020.PMID: 32923663 Free PMC article.
-
NP Safe Prescribing Of Controlled Substances While Avoiding Drug Diversion.2020 Nov 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.PMID: 33232099 Free Books & Documents. Review.
-
Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain.J Pain. 2016 Jun;17(6):739-44. doi: 10.1016/j.jpain.2016.03.002. Epub 2016 Mar 19.PMID: 27001005
-
Suicidal Ideation.2020 Nov 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.PMID: 33351435 Free Books & Documents. Review.
-
Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study.PLoS One. 2017 Nov 16;12(11):e0187795. doi: 10.1371/journal.pone.0187795. eCollection 2017.PMID: 29145417 Free PMC article.